Nationwide Fund Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-418
| Closed | -$206K | – | 2198 |
|
|
2017
Q3 | $206K | Hold |
418
| – | – | ﹤0.01% | 2628 |
|
|
2017
Q2 | $232K | Sell |
418
-82
| -16% | -$45.5K | ﹤0.01% | 2569 |
|
|
2017
Q1 | $331K | Sell |
500
-58
| -10% | -$38.4K | ﹤0.01% | 2369 |
|
|
2016
Q4 | $187K | Sell |
558
-12
| -2% | -$4.02K | ﹤0.01% | 2632 |
|
|
2016
Q3 | $171K | Buy |
570
+9
| +2% | +$2.7K | ﹤0.01% | 2703 |
|
|
2016
Q2 | $97K | Sell |
561
-11
| -2% | -$1.9K | ﹤0.01% | 2928 |
|
|
2016
Q1 | $128K | Sell |
572
-11
| -2% | -$2.46K | ﹤0.01% | 2726 |
|
|
2015
Q4 | $354K | Sell |
583
-351
| -38% | -$213K | ﹤0.01% | 2278 |
|
|
2015
Q3 | $481K | Buy |
934
+397
| +74% | +$204K | ﹤0.01% | 2141 |
|
|
2015
Q2 | $235K | Sell |
537
-18
| -3% | -$7.88K | ﹤0.01% | 2629 |
|
|
2015
Q1 | $201K | Sell |
555
-108
| -16% | -$39.1K | ﹤0.01% | 2689 |
|
|
2014
Q4 | $238K | Sell |
663
-19
| -3% | -$6.82K | ﹤0.01% | 2536 |
|
|
2014
Q3 | $206K | Hold |
682
| – | – | ﹤0.01% | 2670 |
|
|
2014
Q2 | $418K | Buy |
682
+69
| +11% | +$42.3K | ﹤0.01% | 2358 |
|
|
2014
Q1 | $411K | Buy |
+613
| New | +$411K | ﹤0.01% | 2145 |
|